<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">glazmag</journal-id><journal-title-group><journal-title xml:lang="ru">The EYE ГЛАЗ</journal-title><trans-title-group xml:lang="en"><trans-title>The EYE GLAZ</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2222-4408</issn><issn pub-type="epub">2686-8083</issn><publisher><publisher-name>Академия медицинской оптики и оптометрии</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33791/2222-4408-2025-4-368-373</article-id><article-id custom-type="elpub" pub-id-type="custom">glazmag-733</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРАКТИКУМ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>WORKSHOP</subject></subj-group></article-categories><title-group><article-title>Диагностика синдрома сухого глаза (ССГ) шаг за шагом: концепция «Колеса ССГ» в клинической практике офтальмолога и оптометриста</article-title><trans-title-group xml:lang="en"><trans-title>Stepwise diagnosis of dry eye disease (DED): The “Dry Eye Wheel” concept in clinical practice for ophthalmologists and optometrists</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарова</surname><given-names>О. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharova</surname><given-names>O. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Захаровa Ольга Александровна, врач-офтальмолог, руководитель отдела профессионального обучения и развития подразделения заботы о зрении </p><p>125315, г. Москва, Ленинградский пр., д. 72, стр. 3</p></bio><bio xml:lang="en"><p>Olga A. Zakharova, Ophthalmologist, Head of Professional Education and Development, Vision Care Division</p><p>72, Bldg. 3, Leningradsky Ave., Moscow, 125315</p></bio><email xlink:type="simple">olga.zakharova@alcon.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сорокина</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sorokina</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Сорокина Наталья Андреевна, врач-офтальмолог, менеджер по профессиональному обучению и развитию подразделения заботы о зрении </p><p>125315, г. Москва, Ленинградский пр., д. 72, стр. 3</p></bio><bio xml:lang="en"><p>Natalya A. Sorokina, Ophthalmologist, Manager, Professional Education and Development, Vision Care Division</p><p>72, Bldg. 3, Leningradsky Ave., Moscow, 125315</p></bio><email xlink:type="simple">natalya.sorokina@alcon.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ООО «Алкон Фармацевтика»</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Alcon Pharmaceuticals LLC</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>14</day><month>12</month><year>2025</year></pub-date><volume>27</volume><issue>4</issue><fpage>368</fpage><lpage>373</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Академия медицинской оптики и оптометрии, 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Академия медицинской оптики и оптометрии</copyright-holder><copyright-holder xml:lang="en">Академия медицинской оптики и оптометрии</copyright-holder><license xlink:href="https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice" xlink:type="simple"><license-p>https://www.theeyeglaz.com/jour/about/submissions#copyrightNotice</license-p></license></permissions><self-uri xlink:href="https://www.theeyeglaz.com/jour/article/view/733">https://www.theeyeglaz.com/jour/article/view/733</self-uri><abstract><p>Синдром сухого глаза (ССГ) – распространенное и недооцененное заболевание глазной поверхности. Ведение пациентов осложняется разной оснащенностью кабинетов, отсутствием единого алгоритма и разрозненными подходами к диагностике и лечению. В статье представлена концепция «Колеса ССГ» – пошаговый алгоритм, который можно адаптировать к любому уровню ресурсов: от оптики до специализированной клиники. Описаны ключевые элементы модели, основанной на инициативе World Council of Optometry (WCO) «Dry Eye Wheel», а также проверенные клинические инструменты: опросники (OSDI), тесты стабильности слезной пленки, методы окрашивания, оценка осмолярности, морганий, высоты слезного мениска и мейбография. Показан маршрут ведения пациента – от скрининга и простых функциональных проб до уточняющей диагностики и определения типа ССГ (вододефицитный, эвапоративный, смешанный), завершающийся персонализированным лечением и динамическим контролем. Стандартизированный подход по модели «Колесо ССГ» делает диагностику и лечение последовательными и понятными, сокращает время на принятие решений и улучшает качество жизни пациентов. </p></abstract><trans-abstract xml:lang="en"><p>Dry eye disease (DED) is a common and underrecognized condition of the ocular surface. Patient management is complicated by uneven access to diagnostic tools, lack of standardized algorithms, and fragmented approaches to diagnosis and treatment. This article presents the Dry Eye Wheel concept – a stepwise framework adaptable to any level of resources, from optometry practices to specialized clinics. The model, based on the World Council of Optometry (WCO) initiative, integrates validated clinical tools including symptom questionnaires (OSDI), tear film stability tests, ocular surface staining methods, tear osmolarity assessment, blink analysis, tear meniscus height measurement, and meibography. The patient pathway is outlined from screening and simple functional tests to refined diagnostics and subtype identification (aqueous-deficient, evaporative, or mixed), followed by personalized treatment and ongoing monitoring. A structured approach based on the Dry Eye Wheel promotes consistency and clarity in diagnosis and therapy, reduces decision-making time, and enhances patients’ quality of life.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром сухого глаза (ССГ)</kwd><kwd>глазная поверхность</kwd><kwd>OSDI</kwd><kwd>НВРСП</kwd><kwd>осмолярность слезы</kwd><kwd>лиссаминовый зеленый</kwd><kwd>дисфункция мейбомиевых желез (ДМЖ)</kwd><kwd>обучение морганию</kwd></kwd-group><kwd-group xml:lang="en"><kwd>dry eye disease (DED)</kwd><kwd>ocular surface</kwd><kwd>OSDI</kwd><kwd>noninvasive tear break-up time (NITBUT)</kwd><kwd>tear osmolarity</kwd><kwd>lissamine green</kwd><kwd>meibomian gland dysfunction (MGD)</kwd><kwd>blink training</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">World Council of Optometry. Interactive Dry Eye Wheel. URL: https://dryeye.worldcouncilofoptometry.info/interactive-dry-eye-wheel/ (accessed 27.08.2025).</mixed-citation><mixed-citation xml:lang="en">World Council of Optometry. Interactive Dry Eye Wheel. URL: https://dryeye.worldcouncilofoptometry.info/interactive-dry-eye-wheel/ (accessed 27.08.2025).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017 Jul;15(3):539–574. doi: 10.1016/j.jtos.2017.05.001</mixed-citation><mixed-citation xml:lang="en">Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017 Jul;15(3):539–574. doi: 10.1016/j.jtos.2017.05.001</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Jones L, Efron N, Bandamwar K, et al. TFOS lifestyle: impact of contact lenses on the ocular surface. Ocul Surf. 2023;29:175–219.</mixed-citation><mixed-citation xml:lang="en">Jones L, Efron N, Bandamwar K, et al. TFOS lifestyle: impact of contact lenses on the ocular surface. Ocul Surf. 2023;29:175–219.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Wolffsohn JS, Craig JP, Vidal-Rohr M, et al. Blink Test enhances ability to screen for dry eye disease. Cont Lens Anterior Eye. 2018 Oct;41(5):421–425. doi: 10.1016/j.clae.2018.06.003</mixed-citation><mixed-citation xml:lang="en">Wolffsohn JS, Craig JP, Vidal-Rohr M, et al. Blink Test enhances ability to screen for dry eye disease. Cont Lens Anterior Eye. 2018 Oct;41(5):421–425. doi: 10.1016/j.clae.2018.06.003</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Kim AD., et al. Therapeutic benefits of blinking exercises in DED. Cont Lens Anterior Eye. 2020. doi:10.1016/j.clae.2020.04.014</mixed-citation><mixed-citation xml:lang="en">Kim AD., et al. Therapeutic benefits of blinking exercises in DED. Cont Lens Anterior Eye. 2020. doi:10.1016/j.clae.2020.04.014</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Craig JP, Muntz A, Wang MTM, et al. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial. Ocul Surf. 2021 Apr;20:62–69. doi: 10.1016/j.jtos.2020.12.006</mixed-citation><mixed-citation xml:lang="en">Craig JP, Muntz A, Wang MTM, et al. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial. Ocul Surf. 2021 Apr;20:62–69. doi: 10.1016/j.jtos.2020.12.006</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Labetoulle M, Benitez-Del-Castillo JM, Barabino S, et al. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease. Int J Mol Sci. 2022 Feb 23;23(5):2434. doi: 10.3390/ijms23052434</mixed-citation><mixed-citation xml:lang="en">Labetoulle M, Benitez-Del-Castillo JM, Barabino S, et al. Artificial Tears: Biological Role of Their Ingredients in the Management of Dry Eye Disease. Int J Mol Sci. 2022 Feb 23;23(5):2434. doi: 10.3390/ijms23052434</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
